Cargando…
Sustained Response to Entrectinib in an Infant With a Germline ALKAL2 Variant and Refractory Metastatic Neuroblastoma With Chromosomal 2p Gain and Anaplastic Lymphoma Kinase and Tropomyosin Receptor Kinase Activation
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer Health
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830523/ https://www.ncbi.nlm.nih.gov/pubmed/35085006 http://dx.doi.org/10.1200/PO.21.00271 |
| _version_ | 1784648291247456256 |
|---|---|
| author | Treis, Diana Umapathy, Ganesh Fransson, Susanne Guan, Jikui Mendoza-García, Patricia Siaw, Joachim T. Wessman, Sandra Gordon Murkes, Lena Stenman, Jakob J. E. Djos, Anna Elfman, Lotta H. M. Johnsen, John Inge Hallberg, Bengt Palmer, Ruth H. Martinsson, Tommy Kogner, Per |
| author_facet | Treis, Diana Umapathy, Ganesh Fransson, Susanne Guan, Jikui Mendoza-García, Patricia Siaw, Joachim T. Wessman, Sandra Gordon Murkes, Lena Stenman, Jakob J. E. Djos, Anna Elfman, Lotta H. M. Johnsen, John Inge Hallberg, Bengt Palmer, Ruth H. Martinsson, Tommy Kogner, Per |
| author_sort | Treis, Diana |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8830523 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Wolters Kluwer Health |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88305232022-02-11 Sustained Response to Entrectinib in an Infant With a Germline ALKAL2 Variant and Refractory Metastatic Neuroblastoma With Chromosomal 2p Gain and Anaplastic Lymphoma Kinase and Tropomyosin Receptor Kinase Activation Treis, Diana Umapathy, Ganesh Fransson, Susanne Guan, Jikui Mendoza-García, Patricia Siaw, Joachim T. Wessman, Sandra Gordon Murkes, Lena Stenman, Jakob J. E. Djos, Anna Elfman, Lotta H. M. Johnsen, John Inge Hallberg, Bengt Palmer, Ruth H. Martinsson, Tommy Kogner, Per JCO Precis Oncol Case Reports Wolters Kluwer Health 2022-01-27 /pmc/articles/PMC8830523/ /pubmed/35085006 http://dx.doi.org/10.1200/PO.21.00271 Text en © 2022 by American Society of Clinical Oncology https://creativecommons.org/licenses/by/4.0/Licensed under the Creative Commons Attribution 4.0 License: https://creativecommons.org/licenses/by/4.0/ |
| spellingShingle | Case Reports Treis, Diana Umapathy, Ganesh Fransson, Susanne Guan, Jikui Mendoza-García, Patricia Siaw, Joachim T. Wessman, Sandra Gordon Murkes, Lena Stenman, Jakob J. E. Djos, Anna Elfman, Lotta H. M. Johnsen, John Inge Hallberg, Bengt Palmer, Ruth H. Martinsson, Tommy Kogner, Per Sustained Response to Entrectinib in an Infant With a Germline ALKAL2 Variant and Refractory Metastatic Neuroblastoma With Chromosomal 2p Gain and Anaplastic Lymphoma Kinase and Tropomyosin Receptor Kinase Activation |
| title | Sustained Response to Entrectinib in an Infant With a Germline ALKAL2 Variant and Refractory Metastatic Neuroblastoma With Chromosomal 2p Gain and Anaplastic Lymphoma Kinase and Tropomyosin Receptor Kinase Activation |
| title_full | Sustained Response to Entrectinib in an Infant With a Germline ALKAL2 Variant and Refractory Metastatic Neuroblastoma With Chromosomal 2p Gain and Anaplastic Lymphoma Kinase and Tropomyosin Receptor Kinase Activation |
| title_fullStr | Sustained Response to Entrectinib in an Infant With a Germline ALKAL2 Variant and Refractory Metastatic Neuroblastoma With Chromosomal 2p Gain and Anaplastic Lymphoma Kinase and Tropomyosin Receptor Kinase Activation |
| title_full_unstemmed | Sustained Response to Entrectinib in an Infant With a Germline ALKAL2 Variant and Refractory Metastatic Neuroblastoma With Chromosomal 2p Gain and Anaplastic Lymphoma Kinase and Tropomyosin Receptor Kinase Activation |
| title_short | Sustained Response to Entrectinib in an Infant With a Germline ALKAL2 Variant and Refractory Metastatic Neuroblastoma With Chromosomal 2p Gain and Anaplastic Lymphoma Kinase and Tropomyosin Receptor Kinase Activation |
| title_sort | sustained response to entrectinib in an infant with a germline alkal2 variant and refractory metastatic neuroblastoma with chromosomal 2p gain and anaplastic lymphoma kinase and tropomyosin receptor kinase activation |
| topic | Case Reports |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830523/ https://www.ncbi.nlm.nih.gov/pubmed/35085006 http://dx.doi.org/10.1200/PO.21.00271 |
| work_keys_str_mv | AT treisdiana sustainedresponsetoentrectinibinaninfantwithagermlinealkal2variantandrefractorymetastaticneuroblastomawithchromosomal2pgainandanaplasticlymphomakinaseandtropomyosinreceptorkinaseactivation AT umapathyganesh sustainedresponsetoentrectinibinaninfantwithagermlinealkal2variantandrefractorymetastaticneuroblastomawithchromosomal2pgainandanaplasticlymphomakinaseandtropomyosinreceptorkinaseactivation AT franssonsusanne sustainedresponsetoentrectinibinaninfantwithagermlinealkal2variantandrefractorymetastaticneuroblastomawithchromosomal2pgainandanaplasticlymphomakinaseandtropomyosinreceptorkinaseactivation AT guanjikui sustainedresponsetoentrectinibinaninfantwithagermlinealkal2variantandrefractorymetastaticneuroblastomawithchromosomal2pgainandanaplasticlymphomakinaseandtropomyosinreceptorkinaseactivation AT mendozagarciapatricia sustainedresponsetoentrectinibinaninfantwithagermlinealkal2variantandrefractorymetastaticneuroblastomawithchromosomal2pgainandanaplasticlymphomakinaseandtropomyosinreceptorkinaseactivation AT siawjoachimt sustainedresponsetoentrectinibinaninfantwithagermlinealkal2variantandrefractorymetastaticneuroblastomawithchromosomal2pgainandanaplasticlymphomakinaseandtropomyosinreceptorkinaseactivation AT wessmansandra sustainedresponsetoentrectinibinaninfantwithagermlinealkal2variantandrefractorymetastaticneuroblastomawithchromosomal2pgainandanaplasticlymphomakinaseandtropomyosinreceptorkinaseactivation AT gordonmurkeslena sustainedresponsetoentrectinibinaninfantwithagermlinealkal2variantandrefractorymetastaticneuroblastomawithchromosomal2pgainandanaplasticlymphomakinaseandtropomyosinreceptorkinaseactivation AT stenmanjakobje sustainedresponsetoentrectinibinaninfantwithagermlinealkal2variantandrefractorymetastaticneuroblastomawithchromosomal2pgainandanaplasticlymphomakinaseandtropomyosinreceptorkinaseactivation AT djosanna sustainedresponsetoentrectinibinaninfantwithagermlinealkal2variantandrefractorymetastaticneuroblastomawithchromosomal2pgainandanaplasticlymphomakinaseandtropomyosinreceptorkinaseactivation AT elfmanlottahm sustainedresponsetoentrectinibinaninfantwithagermlinealkal2variantandrefractorymetastaticneuroblastomawithchromosomal2pgainandanaplasticlymphomakinaseandtropomyosinreceptorkinaseactivation AT johnsenjohninge sustainedresponsetoentrectinibinaninfantwithagermlinealkal2variantandrefractorymetastaticneuroblastomawithchromosomal2pgainandanaplasticlymphomakinaseandtropomyosinreceptorkinaseactivation AT hallbergbengt sustainedresponsetoentrectinibinaninfantwithagermlinealkal2variantandrefractorymetastaticneuroblastomawithchromosomal2pgainandanaplasticlymphomakinaseandtropomyosinreceptorkinaseactivation AT palmerruthh sustainedresponsetoentrectinibinaninfantwithagermlinealkal2variantandrefractorymetastaticneuroblastomawithchromosomal2pgainandanaplasticlymphomakinaseandtropomyosinreceptorkinaseactivation AT martinssontommy sustainedresponsetoentrectinibinaninfantwithagermlinealkal2variantandrefractorymetastaticneuroblastomawithchromosomal2pgainandanaplasticlymphomakinaseandtropomyosinreceptorkinaseactivation AT kognerper sustainedresponsetoentrectinibinaninfantwithagermlinealkal2variantandrefractorymetastaticneuroblastomawithchromosomal2pgainandanaplasticlymphomakinaseandtropomyosinreceptorkinaseactivation |